The BCR‐ABL fusion gene is a characteristic cytogenetic change in chronic myeloid leukemia and certain ALL patients, resulting from the fusion of the BCR gene of the long arm of chromosome 22 with the ABL gene of the long arm of chromosome 9 (Kang et al., 2016). This evidence concerns the gene BCR and acute lymphoblastic leukemia.